Singapore’s Atomy announced that it hasnot be sold for the time being and sent the product to the Health Sciences Authority for testing.
According to a report by 8 Vision News, Singapore’s Atomy has temporarily removed HemoHIM from its shelves until the investigation is clear. For now, HemoHIM is still licensed and sold in Singapore as a proprietary Chinese medicine (CPM).
Singapore’s Atomy pointed out that the market and e-commerce platforms are flooded with products of unknown origin, so consumers are advised to buy Atomy products only from the official website.
Earlier, the Hong Kong Department of Health said it found that HemoHIM by Atomy, a well-known Korean marketing brand, contained an unlabeled toxic ingredient called Methoxsalen, which may cause liver damage. Four women in Hong Kong were suspected to have been poisoned after taking the product, and it will not be sold for the time being. in Hong Kong.
